The Tapestri Platform is the first and only single-cell multi-omics platform to simultaneously detect single nucleotide variants (SNVs) and indels from the same cell. Move beyond the average readout from conventional bulk sequencing, and uncover the underlying heterogeneity and rare cell populations in cancer research samples.
The average readout from conventional bulk sequencing misses the underlying genetic diversity across cell populations. Single-cell DNA sequencing for single nucleotide variants and indels provides the true measure of clonal heterogeneity without inferring or guessing. Reveal the true clonal architecture in a tumor sample without the assumptions confounded by bulk sequencing.
Identify true mutation co-occurrence in clonal populations.
Detect rare subclones down to 0.1% that may be missed by bulk sequencing.
Determine the zygosity that matters for your disease research.
See how single-cell DNA sequencing reveals clonal evolution in AML patients on gilteritinib.
Cathy Smith, M.D., University of California, San Francisco
Integrate seamlessly into your existing NGS workflow with sample prep and analysis solutions using the Tapestri single-cell sequencing platform
With our single-cell sequencing platform, use the Tapestri Instrument, reagents, and consumables up-front of your NGS system and then Tapestri Pipeline and Tapestri Insights software for data analysis and visualization.